News
Hosted on MSN16d
Macau approves IASO Bio’s multiple myeloma therapyThe Macau Special Administrative Region (ISAF) Pharmaceutical Administration Bureau has approved IASO Biotherapeutics’ new drug application (NDA) for equecabtagene autoleucel to treat adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback